O	O	O	0	4	Some	Some	B-NP	DT	O	2	NMOD	O
O	O	O	5	17	antioxidants	antioxidant	I-NP	NNS	O	3	SUB	O
O	O	O	18	25	inhibit	inhibit	B-VP	VBP	O	0	ROOT	O
O	O	O	25	26	,	,	O	,	O	3	P	O
O	O	O	27	29	in	in	B-PP	IN	O	3	VMOD	O
O	O	O	30	31	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	32	34	co	co	I-NP	AFX	O	10	NMOD	O
O	O	O	34	35	-	-	I-NP	HYPH	O	10	NMOD	O
O	O	O	35	43	ordinate	ordinate	I-NP	JJ	O	10	NMOD	O
O	O	O	44	51	fashion	fashion	I-NP	NN	O	5	PMOD	O
O	O	O	51	52	,	,	O	,	O	3	P	O
O	O	O	53	56	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	57	67	production	production	I-NP	NN	O	3	VMOD	O
O	O	O	68	70	of	of	B-PP	IN	O	13	NMOD	O
T1	B-Protein	B-Protein	71	76	tumor	tumor	B-NP	NN	B-protein	19	NMOD	B-protein
T1	I-Protein	I-Protein	77	85	necrosis	necrosis	I-NP	NN	I-protein	19	NMOD	I-protein
T1	I-Protein	I-Protein	86	92	factor	factor	I-NP	NN	I-protein	19	NMOD	I-protein
T1	I-Protein	I-Protein	92	93	-	-	O	HYPH	I-protein	19	P	I-protein
T1	I-Protein	I-Protein	93	98	alpha	alpha	B-NP	SYM	I-protein	23	NMOD	I-protein
O	O	O	98	99	,	,	O	,	O	23	P	O
T2	B-Protein	B-Protein	100	102	IL	IL	B-NP	NN	B-protein	23	NMOD	B-protein
T2	I-Protein	I-Protein	102	103	-	-	O	HYPH	I-protein	23	NMOD	I-protein
T2	I-Protein	I-Protein	103	107	beta	beta	B-NP	SYM	I-protein	27	NMOD	I-protein
O	O	O	107	108	,	,	O	,	O	27	P	O
O	O	O	109	112	and	and	O	CC	O	27	NMOD	O
T3	B-Protein	B-Protein	113	115	IL	IL	B-NP	NN	B-protein	27	NMOD	B-protein
T3	I-Protein	I-Protein	115	116	-	-	O	HYPH	I-protein	14	PMOD	I-protein
T3	I-Protein	I-Protein	116	117	6	6	B-NP	CD	I-protein	27	NMOD	I-protein
O	O	O	118	120	by	by	B-PP	IN	O	13	NMOD	O
O	O	O	121	126	human	human	B-NP	JJ	B-cell_type	34	NMOD	B-cell_type
O	O	O	127	137	peripheral	peripheral	I-NP	JJ	I-cell_type	34	NMOD	I-cell_type
O	O	O	138	143	blood	blood	I-NP	NN	I-cell_type	34	NMOD	I-cell_type
O	O	O	144	155	mononuclear	mononuclear	I-NP	JJ	I-cell_type	34	NMOD	I-cell_type
O	O	O	156	161	cells	cell	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	O	161	162	.	.	O	.	O	3	P	O

O	O	O	164	168	Some	Some	B-NP	DT	O	2	NMOD	O
O	O	O	169	181	antioxidants	antioxidant	I-NP	NNS	O	0	ROOT	O
O	O	O	181	182	,	,	O	,	O	2	P	O
O	O	O	183	192	including	include	B-PP	VBG	O	2	NMOD	O
O	O	O	193	202	butylated	butylate	B-NP	VBN	O	6	NMOD	O
O	O	O	203	217	hydroxyanisole	hydroxyanisole	I-NP	NN	O	29	SUB	O
O	O	O	218	219	(	(	O	(	O	9	DEP	O
O	O	O	219	222	BHA	BHA	B-NP	NN	O	9	DEP	O
O	O	O	222	223	)	)	O	)	O	6	NMOD	O
O	O	O	223	224	,	,	O	,	O	29	P	O
O	O	O	225	247	tetrahydropapaveroline	tetrahydropapaveroline	B-NP	NN	O	29	SUB	O
O	O	O	248	249	(	(	O	(	O	14	DEP	O
O	O	O	249	252	THP	THP	B-NP	NN	O	14	DEP	O
O	O	O	252	253	)	)	O	)	O	11	NMOD	O
O	O	O	253	254	,	,	O	,	O	29	P	O
O	O	O	255	275	nordihydroguiauretic	nordihydroguiauretic	B-NP	JJ	O	17	NMOD	O
O	O	O	276	280	acid	acid	I-NP	NN	O	29	SUB	O
O	O	O	280	281	,	,	O	,	O	29	P	O
O	O	O	282	285	and	and	O	CC	O	29	VMOD	O
O	O	O	286	288	10	10	B-NP	CD	O	29	SUB	O
O	O	O	288	289	,	,	I-NP	,	O	29	P	O
O	O	O	289	291	11	11	I-NP	CD	O	29	VMOD	O
O	O	O	291	292	-	-	I-NP	HYPH	O	22	NMOD	O
O	O	O	292	310	dihydroxyaporphine	dihydroxyaporphine	I-NP	NN	O	23	OBJ	O
O	O	O	311	312	(	(	O	(	O	27	DEP	O
O	O	O	312	315	DHA	DHA	B-NP	NN	O	27	DEP	O
O	O	O	315	316	)	)	O	)	O	24	NMOD	O
O	O	O	316	317	,	,	O	,	O	29	P	O
O	O	O	318	322	were	be	B-VP	VBD	O	4	SBAR	O
O	O	O	323	328	found	find	I-VP	VBN	O	29	VC	O
O	O	O	329	331	to	to	I-VP	TO	O	32	VMOD	O
O	O	O	332	334	be	be	I-VP	VB	O	30	VMOD	O
O	O	O	335	341	potent	potent	B-NP	JJ	O	34	NMOD	O
O	O	O	342	352	inhibitors	inhibitor	I-NP	NNS	O	32	PRD	O
O	O	O	353	355	of	of	B-PP	IN	O	34	NMOD	O
O	O	O	356	359	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	360	370	production	production	I-NP	NN	O	35	PMOD	O
O	O	O	371	373	of	of	B-PP	IN	O	37	NMOD	O
T4	B-Protein	B-Protein	374	379	tumor	tumor	B-NP	NN	B-protein	46	NMOD	B-protein
T4	I-Protein	I-Protein	380	388	necrosis	necrosis	I-NP	NN	I-protein	46	NMOD	I-protein
T4	I-Protein	I-Protein	389	395	factor	factor	I-NP	NN	I-protein	46	NMOD	I-protein
T4	I-Protein	I-Protein	396	397	(	(	O	(	I-protein	46	NMOD	I-protein
T4	I-Protein	I-Protein	397	400	TNF	TNF	B-NP	NN	I-protein	46	NMOD	I-protein
T4	I-Protein	I-Protein	400	401	)	)	O	)	I-protein	46	NMOD	I-protein
T4	I-Protein	I-Protein	401	402	-	-	O	HYPH	I-protein	46	P	I-protein
T4	I-Protein	I-Protein	402	407	alpha	alpha	B-NP	SYM	I-protein	51	NMOD	I-protein
O	O	O	407	408	,	,	O	,	O	51	P	O
T5	B-Protein	B-Protein	409	411	IL	IL	B-NP	NN	B-protein	51	NMOD	B-protein
T5	I-Protein	I-Protein	411	412	-	-	B-NP	HYPH	I-protein	50	P	I-protein
T5	I-Protein	I-Protein	412	413	1	1	I-NP	CD	I-protein	51	NMOD	I-protein
T5	I-Protein	I-Protein	414	418	beta	beta	B-NP	SYM	I-protein	55	NMOD	I-protein
O	O	O	418	419	,	,	O	,	O	55	P	O
O	O	O	420	423	and	and	O	CC	O	55	NMOD	O
T6	B-Protein	B-Protein	424	426	IL	IL	B-NP	NN	B-protein	55	NMOD	B-protein
T6	I-Protein	I-Protein	426	427	-	-	O	HYPH	I-protein	38	PMOD	I-protein
T6	I-Protein	I-Protein	427	428	6	6	B-NP	CD	I-protein	55	NMOD	I-protein
O	O	O	429	431	by	by	B-PP	IN	O	34	NMOD	O
O	O	O	432	437	human	human	B-NP	JJ	B-cell_type	62	NMOD	B-cell_type
O	O	O	438	448	peripheral	peripheral	I-NP	JJ	I-cell_type	62	NMOD	I-cell_type
O	O	O	449	454	blood	blood	I-NP	NN	I-cell_type	62	NMOD	I-cell_type
O	O	O	455	466	mononuclear	mononuclear	I-NP	JJ	I-cell_type	62	NMOD	I-cell_type
O	O	O	467	472	cells	cell	I-NP	NNS	I-cell_type	57	PMOD	I-cell_type
O	O	O	473	474	(	(	O	(	O	65	DEP	O
O	O	O	474	478	PBMC	PBMC	B-NP	NN	B-cell_type	65	DEP	B-cell_type
O	O	O	478	479	)	)	O	)	O	62	NMOD	O
O	O	O	480	490	stimulated	stimulate	B-VP	VBN	O	62	NMOD	O
O	O	O	491	493	by	by	B-PP	IN	O	66	VMOD	O
O	O	O	494	512	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	67	PMOD	O
O	O	O	513	514	(	(	O	(	O	71	DEP	O
O	O	O	514	517	LPS	LPS	B-NP	NN	O	71	DEP	O
O	O	O	517	518	)	)	O	)	O	68	NMOD	O
O	O	O	519	520	(	(	O	(	O	79	DEP	O
O	O	O	520	525	IC50s	IC50	B-NP	NNS	O	79	DEP	O
O	O	O	526	528	in	in	B-PP	IN	O	73	NMOD	O
O	O	O	529	532	the	the	B-NP	DT	O	78	NMOD	O
O	O	O	533	536	low	low	I-NP	JJ	O	77	AMOD	O
O	O	O	537	547	micromolar	micromolar	I-NP	JJ	O	78	NMOD	O
O	O	O	548	553	range	range	I-NP	NN	O	74	PMOD	O
O	O	O	553	554	)	)	O	)	O	68	NMOD	O
O	O	O	554	555	.	.	O	.	O	2	P	O

O	O	O	556	566	Inhibition	Inhibition	B-NP	NN	O	5	SUB	O
O	O	O	567	569	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	570	578	cytokine	cytokine	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	579	589	production	production	I-NP	NN	O	2	PMOD	O
O	O	O	590	593	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	594	598	gene	gene	B-NP	NN	O	10	PRD	O
O	O	O	599	608	selective	selective	B-ADJP	JJ	O	6	AMOD	O
O	O	O	609	612	and	and	O	CC	O	10	AMOD	O
O	O	O	613	616	not	not	B-ADJP	RB	O	10	AMOD	O
O	O	O	617	620	due	due	I-ADJP	JJ	O	5	PRD	O
O	O	O	621	623	to	to	B-PP	TO	O	10	AMOD	O
O	O	O	624	631	general	general	B-NP	JJ	O	13	NMOD	O
O	O	O	632	639	effects	effect	I-NP	NNS	O	11	PMOD	O
O	O	O	640	642	on	on	B-PP	IN	O	13	NMOD	O
O	O	O	643	650	protein	protein	B-NP	NN	O	16	NMOD	O
O	O	O	651	660	synthesis	synthesis	I-NP	NN	O	14	PMOD	O
O	O	O	660	661	.	.	O	.	O	5	P	O

O	O	O	662	672	Inhibition	Inhibition	B-NP	NN	O	7	SUB	O
O	O	O	673	675	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	676	684	cytokine	cytokine	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	685	695	production	production	I-NP	NN	O	2	PMOD	O
O	O	O	696	698	by	by	B-PP	IN	O	4	NMOD	O
O	O	O	699	703	PBMC	PBMC	B-NP	NN	B-cell_type	5	PMOD	B-cell_type
O	O	O	704	707	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	708	716	observed	observe	I-VP	VBN	O	7	VC	O
O	O	O	717	721	also	also	B-ADVP	RB	O	8	VMOD	O
O	O	O	722	726	when	when	B-ADVP	WRB	O	8	VMOD	O
O	O	O	727	732	other	other	B-NP	JJ	O	12	NMOD	O
O	O	O	733	741	inducers	inducer	I-NP	NNS	O	13	SUB	O
O	O	O	742	746	were	be	B-VP	VBD	O	10	SBAR	O
O	O	O	747	751	used	use	I-VP	VBN	O	13	VC	O
O	O	O	752	753	(	(	O	(	O	21	DEP	O
O	O	O	753	766	staphylococci	staphylococci	B-NP	NNS	O	20	NMOD	O
O	O	O	766	767	,	,	O	,	O	20	P	O
O	O	O	768	774	silica	silica	B-NP	NN	O	20	NMOD	O
O	O	O	774	775	,	,	O	,	O	20	P	O
O	O	O	776	783	zymosan	zymosan	B-NP	NN	O	21	DEP	O
O	O	O	783	784	)	)	O	)	O	7	VMOD	O
O	O	O	784	785	.	.	O	.	O	7	P	O

O	O	O	786	790	Much	Much	B-NP	RB	O	2	AMOD	O
O	O	O	791	797	higher	high	I-NP	JJR	O	3	NMOD	O
O	O	O	798	812	concentrations	concentration	I-NP	NNS	O	31	SUB	O
O	O	O	813	815	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	816	821	other	other	B-NP	JJ	O	6	NMOD	O
O	O	O	822	834	antioxidants	antioxidant	I-NP	NNS	O	4	PMOD	O
O	O	O	834	835	-	-	B-ADJP	HYPH	O	3	P	O
O	O	O	835	836	-	-	B-PP	HYPH	O	3	P	O
O	O	O	836	845	including	include	B-PP	VBG	O	3	NMOD	O
O	O	O	846	854	ascorbic	ascorbic	B-NP	JJ	O	11	NMOD	O
O	O	O	855	859	acid	acid	I-NP	NN	O	13	NMOD	O
O	O	O	859	860	,	,	O	,	O	13	P	O
O	O	O	861	867	trolox	trolox	B-NP	NN	O	9	PMOD	O
O	O	O	867	868	,	,	O	,	O	30	P	O
O	O	O	869	874	alpha	alpha	O	SYM	O	30	NMOD	O
O	O	O	874	875	-	-	O	HYPH	O	30	P	O
O	O	O	875	885	tocopherol	tocopherol	B-NP	NN	O	30	NMOD	O
O	O	O	885	886	,	,	O	,	O	30	P	O
O	O	O	887	896	butylated	butylate	B-VP	VBN	O	20	NMOD	O
O	O	O	897	911	hydroxytoluene	hydroxytoluene	B-NP	NN	O	30	NMOD	O
O	O	O	911	912	,	,	O	,	O	30	P	O
O	O	O	913	916	and	and	O	CC	O	30	NMOD	O
O	O	O	917	920	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	921	922	5	5	I-NP	CD	O	28	NMOD	O
O	O	O	922	923	-	-	I-NP	HYPH	O	28	P	O
O	O	O	923	935	lipoxygenase	lipoxygenase	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	936	945	inhibitor	inhibitor	I-NP	NN	O	28	NMOD	O
O	O	O	946	954	zileuton	zileuton	I-NP	NN	O	30	NMOD	O
O	O	O	954	955	-	-	O	HYPH	O	30	P	O
O	O	O	955	956	-	-	B-NP	SYM	O	31	P	O
O	O	O	956	959	did	do	B-VP	VBD	O	0	ROOT	O
O	O	O	960	963	not	not	I-VP	RB	O	31	VMOD	O
O	O	O	964	970	affect	affect	I-VP	VB	O	31	VC	O
O	O	O	971	974	the	the	B-NP	DT	O	35	NMOD	O
O	O	O	975	985	production	production	I-NP	NN	O	33	OBJ	O
O	O	O	986	988	of	of	B-PP	IN	O	35	NMOD	O
O	O	O	989	994	these	these	B-NP	DT	O	38	NMOD	O
O	O	O	995	1004	cytokines	cytokine	I-NP	NNS	B-protein	36	PMOD	B-protein
O	O	O	1004	1005	.	.	O	.	O	31	P	O

O	O	O	1006	1009	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1010	1016	active	active	I-NP	JJ	O	3	NMOD	O
O	O	O	1017	1026	compounds	compound	I-NP	NNS	O	4	SUB	O
O	O	O	1027	1030	did	do	B-VP	VBD	O	0	ROOT	O
O	O	O	1031	1034	not	not	I-VP	RB	O	4	VMOD	O
O	O	O	1035	1042	inhibit	inhibit	I-VP	VB	O	4	VC	O
O	O	O	1043	1045	IL	IL	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1045	1046	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
O	O	O	1046	1047	1	1	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	O	1047	1048	-	-	B-NP	HYPH	O	8	P	O
O	O	O	1048	1055	induced	induce	I-NP	VBN	O	12	NMOD	O
O	O	O	1056	1066	production	production	I-NP	NN	O	6	OBJ	O
O	O	O	1067	1069	of	of	B-PP	IN	O	12	NMOD	O
T7	B-Protein	B-Protein	1070	1072	IL	IL	B-NP	NN	B-protein	15	NMOD	B-protein
T7	I-Protein	I-Protein	1072	1073	-	-	B-NP	HYPH	I-protein	13	PMOD	I-protein
T7	I-Protein	I-Protein	1073	1074	6	6	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	O	1075	1077	in	in	B-PP	IN	O	12	NMOD	O
O	O	O	1078	1089	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	17	PMOD	B-cell_type
O	O	O	1089	1090	,	,	O	,	O	4	P	O
O	O	O	1091	1098	showing	show	B-VP	VBG	O	4	VMOD	O
O	O	O	1099	1102	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	1103	1107	cell	cell	I-NP	NN	O	23	NMOD	O
O	O	O	1108	1119	selectivity	selectivity	I-NP	NN	O	20	OBJ	O
O	O	O	1120	1122	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	1123	1126	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	1127	1133	effect	effect	I-NP	NN	O	24	PMOD	O
O	O	O	1133	1134	.	.	O	.	O	4	P	O

O	O	O	1135	1146	Antioxidant	Antioxidant	B-NP	NN	O	8	SUB	O
O	O	O	1146	1147	-	-	B-PP	HYPH	O	1	NMOD	O
O	O	O	1147	1155	mediated	mediate	B-NP	VBN	O	4	NMOD	O
O	O	O	1156	1166	inhibition	inhibition	I-NP	NN	O	2	PMOD	O
O	O	O	1167	1169	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	1170	1178	cytokine	cytokine	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	1179	1189	production	production	I-NP	NN	O	5	PMOD	O
O	O	O	1190	1193	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1194	1204	correlated	correlate	I-VP	VBN	O	8	VC	O
O	O	O	1205	1209	with	with	B-PP	IN	O	9	VMOD	O
O	O	O	1210	1213	low	low	B-NP	JJ	O	12	NMOD	O
O	O	O	1214	1220	levels	level	I-NP	NNS	O	10	PMOD	O
O	O	O	1221	1223	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	1224	1227	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	1228	1241	corresponding	correspond	I-NP	VBG	O	17	NMOD	O
O	O	O	1242	1251	messenger	messenger	I-NP	NN	B-RNA	17	NMOD	B-RNA
O	O	O	1252	1256	RNAs	RNA	I-NP	NNS	I-RNA	13	PMOD	I-RNA
O	O	O	1256	1257	.	.	O	.	O	8	P	O

O	O	O	1258	1265	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD	O
O	O	O	1266	1269	run	run	I-NP	NN	O	6	SUB	O
O	O	O	1269	1270	-	-	B-ADVP	HYPH	O	2	P	O
O	O	O	1270	1272	on	on	B-PP	IN	O	2	NMOD	O
O	O	O	1273	1284	experiments	experiment	B-NP	NNS	O	4	PMOD	O
O	O	O	1285	1291	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	1292	1296	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	1297	1300	THP	THP	B-NP	NN	O	9	SUB	O
O	O	O	1301	1310	inhibited	inhibit	B-VP	VBD	O	7	SBAR	O
O	O	O	1311	1324	transcription	transcription	B-NP	NN	O	9	OBJ	O
O	O	O	1325	1327	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	1328	1331	the	the	B-NP	DT	O	17	NMOD	O
T8	B-Protein	B-Protein	1332	1334	IL	IL	I-NP	NN	B-DNA	17	NMOD	B-DNA
T8	I-Protein	I-Protein	1334	1335	-	-	O	HYPH	I-DNA	17	NMOD	I-DNA
T8	I-Protein	I-Protein	1335	1336	1	1	B-NP	CD	I-DNA	17	NMOD	I-DNA
T8	I-Protein	I-Protein	1337	1341	beta	beta	I-NP	SYM	I-DNA	17	NMOD	I-DNA
O	O	O	1342	1346	gene	gene	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	O	1346	1347	.	.	O	.	O	6	P	O

O	O	O	1348	1351	THP	THP	B-NP	NN	O	2	SUB	O
O	O	O	1352	1361	decreased	decrease	B-VP	VBD	O	0	ROOT	O
O	O	O	1362	1365	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	1366	1379	concentration	concentration	I-NP	NN	O	2	OBJ	O
O	O	O	1380	1382	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	1383	1386	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1387	1400	transcription	transcription	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1401	1408	factors	factor	I-NP	NNS	I-protein	5	PMOD	I-protein
T11	B-Entity	B-Entity	1409	1411	NF	NF	B-VP	NN	B-protein	8	NMOD	B-protein
T11	I-Entity	I-Entity	1411	1412	-	-	O	HYPH	I-protein	15	NMOD	I-protein
T11	I-Entity	I-Entity	1412	1417	kappa	kappa	B-NP	NN	I-protein	12	NMOD	I-protein
T11	I-Entity	I-Entity	1418	1419	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	1420	1423	and	and	O	CC	O	15	NMOD	O
O	O	O	1424	1426	AP	AP	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	O	1426	1427	-	-	B-NP	HYPH	I-protein	9	P	I-protein
O	O	O	1427	1428	1	1	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	O	1429	1437	detected	detect	B-VP	VBN	O	8	NMOD	O
O	O	O	1438	1440	in	in	B-PP	IN	O	17	VMOD	O
O	O	O	1441	1448	nuclear	nuclear	B-NP	JJ	O	20	NMOD	O
O	O	O	1449	1457	extracts	extract	I-NP	NNS	O	18	PMOD	O
O	O	O	1458	1460	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1461	1465	PBMC	PBMC	B-NP	NN	B-cell_type	21	PMOD	B-cell_type
O	O	O	1466	1474	cultured	culture	B-VP	VBN	O	22	NMOD	O
O	O	O	1475	1477	in	in	B-PP	IN	O	23	VMOD	O
O	O	O	1478	1481	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	1482	1490	presence	presence	I-NP	NN	O	28	NMOD	O
O	O	O	1491	1493	or	or	I-NP	CC	O	28	NMOD	O
O	O	O	1494	1501	absence	absence	I-NP	NN	O	24	PMOD	O
O	O	O	1502	1504	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	1505	1508	LPS	LPS	B-NP	NN	O	29	PMOD	O
O	O	O	1508	1509	.	.	O	.	O	2	P	O

O	O	O	1510	1513	THP	THP	B-NP	NN	O	3	NMOD	O
O	O	O	1514	1517	and	and	I-NP	CC	O	3	NMOD	O
O	O	O	1518	1521	DHA	DHA	I-NP	NN	O	5	SUB	O
O	O	O	1522	1530	markedly	markedly	B-ADVP	RB	O	5	VMOD	O
O	O	O	1531	1540	decreased	decrease	B-VP	VBD	O	0	ROOT	O
O	O	O	1541	1544	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1545	1551	levels	level	I-NP	NNS	O	5	OBJ	O
O	O	O	1552	1554	of	of	B-PP	IN	O	7	NMOD	O
T9	B-Protein	B-Protein	1555	1558	TNF	TNF	B-NP	NN	B-protein	16	NMOD	B-protein
T9	I-Protein	I-Protein	1558	1559	-	-	O	HYPH	O	16	P	O
T9	I-Protein	I-Protein	1559	1564	alpha	alpha	B-NP	SYM	O	16	NMOD	O
O	O	O	1565	1568	and	and	O	CC	O	16	NMOD	O
T10	B-Protein	B-Protein	1569	1571	IL	IL	B-NP	NN	B-protein	16	NMOD	B-protein
T10	I-Protein	I-Protein	1571	1572	-	-	O	HYPH	I-protein	16	NMOD	I-protein
T10	I-Protein	I-Protein	1572	1573	1	1	B-NP	CD	I-protein	16	NMOD	I-protein
T10	I-Protein	I-Protein	1574	1578	beta	beta	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	1579	1581	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	1582	1585	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	1586	1597	circulation	circulation	I-NP	NN	O	17	PMOD	O
O	O	O	1598	1600	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	1601	1605	mice	mouse	B-NP	NNS	O	20	PMOD	O
O	O	O	1606	1615	following	follow	B-PP	VBG	O	21	NMOD	O
O	O	O	1616	1619	LPS	LPS	B-NP	NN	O	24	NMOD	O
O	O	O	1620	1629	injection	injection	I-NP	NN	O	22	PMOD	O
O	O	O	1629	1630	.	.	O	.	O	5	P	O

O	O	O	1631	1635	Thus	Thus	B-NP	RB	O	3	VMOD	O
O	O	O	1636	1648	antioxidants	antioxidant	I-NP	NNS	O	3	SUB	O
O	O	O	1649	1653	vary	vary	B-VP	VBP	O	0	ROOT	O
O	O	O	1654	1660	widely	widely	B-ADVP	RB	O	3	VMOD	O
O	O	O	1661	1663	in	in	B-PP	IN	O	3	VMOD	O
O	O	O	1664	1671	potency	potency	B-NP	NN	O	5	PMOD	O
O	O	O	1672	1674	as	as	B-PP	IN	O	3	VMOD	O
O	O	O	1675	1685	inhibitors	inhibitor	B-NP	NNS	O	7	PMOD	O
O	O	O	1686	1688	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1689	1692	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	1693	1703	activation	activation	I-NP	NN	O	9	PMOD	O
O	O	O	1704	1706	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1707	1720	transcription	transcription	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	1721	1728	factors	factor	I-NP	NNS	I-protein	12	PMOD	I-protein
O	O	O	1729	1732	and	and	B-PP	CC	O	12	PMOD	O
O	O	O	1733	1735	of	of	B-PP	IN	O	12	PMOD	O
O	O	O	1736	1739	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	1740	1753	transcription	transcription	I-NP	NN	O	16	PMOD	O
O	O	O	1754	1756	of	of	B-PP	IN	O	18	NMOD	O
T12	B-Entity	B-Entity	1757	1762	genes	gene	B-NP	NNS	O	19	PMOD	O
O	O	O	1763	1766	for	for	B-PP	IN	O	20	NMOD	O
O	O	O	1767	1770	pro	pro	B-NP	AFX	B-cell_type	25	NMOD	B-cell_type
O	O	O	1770	1771	-	-	I-NP	HYPH	O	25	NMOD	O
O	O	O	1771	1783	inflammatory	inflammatory	I-NP	JJ	B-protein	25	NMOD	B-protein
O	O	O	1784	1793	cytokines	cytokine	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	O	1793	1794	.	.	O	.	O	3	P	O

O	O	O	1795	1805	Coordinate	Coordinate	B-NP	JJ	O	2	NMOD	O
O	O	O	1806	1816	inhibition	inhibition	I-NP	NN	O	11	SUB	O
O	O	O	1817	1819	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1820	1823	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1824	1837	transcription	transcription	I-NP	NN	O	3	PMOD	O
O	O	O	1838	1840	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1841	1846	genes	gene	B-NP	NNS	O	6	PMOD	O
O	O	O	1847	1850	for	for	B-PP	IN	O	7	NMOD	O
O	O	O	1851	1863	inflammatory	inflammatory	B-NP	JJ	B-protein	10	NMOD	B-protein
O	O	O	1864	1873	cytokines	cytokine	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	O	1874	1879	could	could	B-VP	MD	O	0	ROOT	O
O	O	O	1880	1887	provide	provide	I-VP	VB	O	11	VC	O
O	O	O	1888	1889	a	a	B-NP	DT	O	14	NMOD	O
O	O	O	1890	1898	strategy	strategy	I-NP	NN	O	12	OBJ	O
O	O	O	1899	1902	for	for	B-PP	IN	O	14	NMOD	O
O	O	O	1903	1910	therapy	therapy	B-NP	NN	O	15	PMOD	O
O	O	O	1911	1913	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1914	1922	diseases	disease	B-NP	NNS	O	17	PMOD	O
O	O	O	1923	1927	with	with	B-PP	IN	O	16	NMOD	O
O	O	O	1928	1940	inflammatory	inflammatory	B-NP	JJ	O	21	NMOD	O
O	O	O	1941	1953	pathogenesis	pathogenesis	I-NP	NN	O	19	PMOD	O
O	O	O	1954	1957	and	and	B-PP	CC	O	19	PMOD	O
O	O	O	1958	1961	for	for	B-PP	IN	O	19	PMOD	O
O	O	O	1962	1968	septic	septic	B-NP	JJ	O	25	NMOD	O
O	O	O	1969	1974	shock	shock	I-NP	NN	O	23	PMOD	O
O	O	O	1974	1975	.	.	O	.	O	11	P	O
